Cited by 208Pulmonary Hypertension Research and TreatmentsVascular Anomalies and TreatmentsAngiogenesis and VEGF in Cancer

Increased Pericyte Coverage Mediated by Endothelial-Derived Fibroblast Growth Factor-2 and Interleukin-6 Is a Source of Smooth Muscle–Like Cells in Pulmonary Hypertension

Ricard, Nicolas, Tu, Ly, Le Hiress, Morane, Huertas, Alice, Phan, Carole, Thuillet, Raphaël, Sattler, Caroline, Fadel, Elie +5 more·2014·Circulation

Abstract

Background—: Pericytes and their crosstalk with endothelial cells are critical for the development of a functional microvasculature and vascular remodeling. It is also known that pulmonary endothelial dysfunction is intertwined with the initiation and progression of pulmonary arterial hypertension (PAH). We hypothesized that pulmonary endothelial dysfunction, characterized by abnormal fibroblast growth factor-2 and interleukin-6 signaling, leads to abnormal microvascular pericyte coverage causing pulmonary arterial medial thickening. Methods and Results—: In human lung tissues, numbers of pericytes are substantially increased (up to 2-fold) in distal PAH pulmonary arteries compared with controls. Interestingly, human pulmonary pericytes exhibit, in vitro, an accentuated proliferative and migratory response to conditioned media from human idiopathic PAH endothelial cells compared with conditioned media from control cells. Importantly, by using an anti–fibroblast growth factor-2 neutralizing antibody, we attenuated these proliferative and migratory responses, whereas by using an anti–interleukin-6 neutralizing antibody, we decreased the migratory response without affecting the proliferative response. Furthermore, in our murine retinal angiogenesis model, both fibroblast growth factor-2 and interleukin-6 administration increased pericyte coverage. Finally, using idiopathic PAH human and NG2DsRedBAC mouse lung tissues, we demonstrated that this increased pericyte coverage contributes to pulmonary vascular remodeling as a source of smooth muscle–like cells. Furthermore, we found that transforming growth factor-β, in contrast to fibroblast growth factor-2 and interleukin-6, promotes human pulmonary pericyte differentiation into contractile smooth muscle–like cells. Conclusions—: To the best of our knowledge, this is the first report of excessive pericyte coverage in distal pulmonary arteries in human PAH. We also show that this phenomenon is directly linked with pulmonary endothelial dysfunction.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.113.007469

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Proper expression of IL-6 by pericytes is important for the integrity of the BBB.

    “The proper expression of IL-6 by pericytes was suggested to be important for the integrity of BBB.507,508”

    From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [507]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ricard, N., Tu, L., Le Hiress, M., Huertas, A., Phan, C., Thuillet, R., Sattler, C., Fadel, E., Seferian, A., Montani, D., Dorfmüller, P., Humbert, M., & Guignabert, C.
Affiliations
  • Inserm (FR)
  • From the National Institute of Health and Medical Research, Unit 999, LabEx Laboratory of Excellence in Research on Medication and Innovative Therapeutics, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France (N.R., L.T., M.L.H., A.H., C.P., R.T., C.S., E.F., A.S., D.M., P.D., M.H., C.G.); University Paris-Sud, School of Medicine, Kremlin-Bicêtre, France (N.R., L.T., M.L.H., A.H., C.P., R.T., C.S., E.F., A.S., D.M., P.D., M.H., C.G.); and Public Hospitals of Paris, Pneumology Service,...
Venue
Circulation
Published
2014-04-15
Volume
129
Issue
15
Pages
1586-1597
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W1975693842
Cited by
208
References
1
Citations by year
2026: 6 · 2025: 11 · 2024: 15 · 2023: 19 · 2022: 14 · 2021: 14 · 2020: 26 · 2019: 16 · 2018: 24 · 2017: 14 · 2016: 20 · 2015: 19 · 2014: 9 · 2013: 1
FWCI
16.48
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • National Institute for Health and Care Research
  • Agence Nationale de la Recherche (ANR-12-JSV1-0004)
  • Institut National de la Santé et de la Recherche Médicale
  • National Institutes of Health
  • CHIST-ERA
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Health Sciences › Medicine › Genetics › Vascular Anomalies and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
pulmonary arterial hypertension, pericytes, pericyte coverage, endothelial dysfunction, fibroblast growth factor 2, interleukin-6, smooth muscle-like cells, pulmonary vascular remodeling, TGF-beta
MeSH terms
Adult, Animals, Cell Communication, Cell Differentiation, Cells, Cultured, Disease Models, Animal, Female, Humans, Hypertension, Pulmonary, Male, Mice, Transgenic, Microcirculation, Middle Aged, Muscle, Smooth, Vascular, Pulmonary Circulation, Retinal Vessels, Interleukin-6, Fibroblast Growth Factor 2, Rats, Wistar, Neovascularization, Physiologic, Pericytes, Endothelial Cells, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review